NewTimeSpace News: Shenzhen Transsion Holdings Co., Ltd. (688036.SH) refiled its H-share listing application with the Hong Kong Stock Exchange on 18 June, with CITIC Securities acting as the sole sponsor. Ranked the No.1 mobile phone supplier across global emerging markets by 2024 shipment volume, it takes the top position in Africa and emerging Asia Pacific regions, with sales footprint covering over 100 countries and territories. The Group shipped 169 million mobile handsets in 2025, and Transsion OS recorded over 290 million monthly active users.
NewTimeSpace News: CSPC Innovation Pharmaceutical Co., Ltd. refiled its listing application with the Hong Kong Stock Exchange on 18 June, with CITIC Securities acting as the sole sponsor. The company ranks as the world’s largest manufacturer of chemically synthesized caffeine by revenue and shipment volume from 2020 to 2025, serving major global clients including The Coca-Cola Company, PepsiCo and Red Bull GmbH. Its business portfolio has expanded into health food, functional pharmaceutical APIs and biopharmaceuticals covering antibodies, ADCs and mRNA vaccines; the Group acquired equity interest in Jushi Bio in 2024 to foray into biotech.
NewTimeSpace News: Jiangxi Institute of Biological Products Inc. (06915.HK) commences its public offering on 22 June, with a board lot of 500 shares and an entry fee of roughly HK$6,595.86. The offer price range is HK$9.33 to HK$13.06 per share. The Company plans a global offering of approximately 36.2345 million H-shares and expects to list on 30 June. WSH has been introduced as the sole cornerstone investor with a total subscription consideration of HK$50 million. Based on the median offer price of HK$11.20, it will subscribe for around 4.464 million Offer Shares, accounting for approximately 12.32% of the total Global Offering shares (assuming the Over-allotment Option is not exercised).
NewTimeSpace News: Guangdong True Health Medical Technology Development Co., Ltd. (02697.HK) kicks off its public offering on 22 June, with a board lot size of 20 shares and an entry fee of roughly HK$2,735.30. The offer price range is HK$119.30 to HK$135.40 per share. The Company plans a global offering of approximately 3.5647 million H-shares and expects to list on 30 June. No cornerstone investors have been introduced for this offering.
NewTimeSpace News: Zhejiang Laifual Drive Co., Ltd. (03952.HK) commences its public offering on 22 June, with a board lot of 100 shares and an entry fee of roughly HK$8,636.22. The offer price range stands at HK$77.00 to HK$85.50 per share. The Company plans a global offering of approximately 13.4419 million H-shares and expects to list on 30 June. Ten cornerstone investors including Oaktree, Mingshan Capital, Harvest Global and CDH Global have been introduced, collectively subscribing for 5.3036 million Offer Shares, accounting for around 39.44% of the total Global Offering shares (assuming the Over-allotment Option is not exercised).
NewTimeSpace News: Hangzhou Qiandaohu Xunlong Sci-tech Co., Ltd. (06715.HK) kicks off its public offering on 22 June, with a board lot size of 100 shares and an entry fee of roughly HK$7,626. The Company plans a global offering of approximately 16.3329 million H-shares at an offer price of HK$75.50 per share, with listing scheduled for 30 June. It has secured eight cornerstone investors including BlackRock Funds, Baring, Taikang Life and Greenwoods Asset Management, with aggregate subscription amount equivalent to around US$78.5 million.
NewTimeSpace News: Shares of Shenzhen HQVT Technology Co., Ltd. traded at HK$23.76 in today’s grey market session, representing a rise of HK$16.56 or 230% compared with the offer price of HK$7.2. The Company will be formally listed on the HKEX Main Board on 22 June.
NewTimeSpace News: The listing application submitted by EpimAb Biotherapeutics Inc. to the Hong Kong Stock Exchange on 18 December 2025 has lapsed upon the expiry of the six-month validity period, with CITIC Securities and CMB International Capital serving as the original joint sponsors. Founded in 2015, the Company is a clinical-stage biotech enterprise focusing on the development of bispecific antibodies for various cancers and autoimmune diseases. Its core asset EMB-01 (targeting EGFR/cMET) is mainly indicated for metastatic colorectal cancer, currently under Phase II monotherapy development and Phase Ib combination therapy development.
NewTimeSpace News: The listing application submitted by COREE Company Limited to the Hong Kong Stock Exchange on 18 December 2025 has lapsed upon the expiry of the six-month validity period, with China International Capital Corporation acting as the original sole sponsor. Originated from South Korea, the Company is an integrated healthcare solution provider with core operations in China and expanding global footprint. According to Frost & Sullivan, measured by 2024 revenue, it ranks as China’s largest service provider for paediatric pharmaceutical marketing, promotion and sales, capturing approximately 15.9% of the domestic market share.
NewTimeSpace News: Chaozhou Three-Circle (Group) Co., Ltd.(300408.SZ) passed the hearing of Hong Kong Stock Exchange Listing Committee on June 18, with China Galaxy International acting as the sole sponsor. With over 55 years of operation focusing on electronic ceramic materials and components, the Company recorded a revenue CAGR exceeding 24% and a net profit CAGR exceeding 28% from 2023 to 2025. Its product portfolio covers core application sectors including communications, AI & data centers, consumer electronics, automotive electronics, semiconductor manufacturing and packaging.
NewTimeSpace News: Jiangsu Boqian New Materials Stock Co., Ltd. (605376.SH) filed a listing application with the Hong Kong Stock Exchange on June 17, with Guotai Junan International acting as the sole sponsor. A world-renowned supplier of electronic-grade metal powder materials, the Company focuses on the R&D, production and sales of high-end metal powders supported by its self-developed PVD-centered technology platform. According to Frost & Sullivan, measured by 2025 revenue, the Company holds an 11.0% global market share in nickel powder for MLCC, ranking second worldwide.
NewTimeSpace News: BANU INTERNATIONAL HOLDING LTD submitted its third listing application to the Hong Kong Stock Exchange on June 17, with CICC and CMBI International acting as joint sponsors. According to Frost & Sullivan, measured by revenue, the Company ranked as the top brand in China’s premium hot pot market in 2025 with a market share of approximately 3.6%, and the second-largest brand in China’s overall hot pot market with a market share of roughly 0.4%. As of the latest practicable date, the Company’s direct-operated store network spans 57 cities nationwide with 200 outlets, representing a 132.6% increase compared with the beginning of 2023.
Newtimespace.com reports: Crealights Technology (1191.HK) launches its global offering of approximately 13.43 million H-shares at an offer price of HK$114.00 per share. The Hong Kong public subscription runs from June 18 to June 24, with an expected listing date of June 29. Huatai International serves as the sole sponsor.
Newtimespace.com reports: Baige Online (2672.HK) launches its global offering of approximately 33.34 million H-shares, with a maximum offer price of HK$20.28 and a minimum expected price of HK$15.60 per share. The Hong Kong public subscription runs from June 18 to June 24, with an expected listing date of June 29.
Newtimespace.com reports: Alebund Pharmaceuticals (09637.HK) launches its global offering of approximately 56.76 million H-shares at an offer price of HK$22.60 per share. The Hong Kong public subscription runs from June 18 to June 24, with an expected listing date of June 29. Jefferies, BofA Securities, and Huatai International serve as joint sponsors.
NewTimeSpace News: Beijing Rongxin Datainfo Science and Technology Co., Ltd. submitted a listing application to the Hong Kong Stock Exchange on June 17, with RAINBOW as the sole sponsor. The Company mainly engages in decision intelligence solutions. In 2025, it ranked ninth in China’s decision intelligence application industry with a market share of 1.3%, and took the first place in the data-agent-driven sub-sector with a market share of 10.5%.
